These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32312974)

  • 1. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance.
    Roumans KHM; Lindeboom L; Veeraiah P; Remie CME; Phielix E; Havekes B; Bruls YMH; Brouwers MCGJ; Ståhlman M; Alssema M; Peters HPF; de Mutsert R; Staels B; Taskinen MR; Borén J; Schrauwen P; Schrauwen-Hinderling VB
    Nat Commun; 2020 Apr; 11(1):1891. PubMed ID: 32312974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
    Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
    J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.
    Lee JJ; Lambert JE; Hovhannisyan Y; Ramos-Roman MA; Trombold JR; Wagner DA; Parks EJ
    Am J Clin Nutr; 2015 Jan; 101(1):34-43. PubMed ID: 25527748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.
    Green CJ; Marjot T; Walsby-Tickle J; Charlton C; Cornfield T; Westcott F; Pinnick KE; Moolla A; Hazlehurst JM; McCullagh J; Tomlinson JW; Hodson L
    Eur J Endocrinol; 2022 Feb; 186(3):367-377. PubMed ID: 35038311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients.
    Lawitz EJ; Li KW; Nyangau E; Field TJ; Chuang JC; Billin A; Wang L; Wang Y; Huss RS; Chung C; Subramanian GM; Myers RP; Hellerstein MK
    J Lipid Res; 2022 Sep; 63(9):100250. PubMed ID: 35835205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans.
    Roberts R; Hodson L; Dennis AL; Neville MJ; Humphreys SM; Harnden KE; Micklem KJ; Frayn KN
    Diabetologia; 2009 May; 52(5):882-90. PubMed ID: 19252892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic oleate regulates adipose tissue lipogenesis and fatty acid oxidation.
    Burhans MS; Flowers MT; Harrington KR; Bond LM; Guo CA; Anderson RM; Ntambi JM
    J Lipid Res; 2015 Feb; 56(2):304-18. PubMed ID: 25555387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.
    Luukkonen PK; Sädevirta S; Zhou Y; Kayser B; Ali A; Ahonen L; Lallukka S; Pelloux V; Gaggini M; Jian C; Hakkarainen A; Lundbom N; Gylling H; Salonen A; Orešič M; Hyötyläinen T; Orho-Melander M; Rissanen A; Gastaldelli A; Clément K; Hodson L; Yki-Järvinen H
    Diabetes Care; 2018 Aug; 41(8):1732-1739. PubMed ID: 29844096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly.
    Flannery C; Dufour S; Rabøl R; Shulman GI; Petersen KF
    Diabetes; 2012 Nov; 61(11):2711-7. PubMed ID: 22829450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fatty acid synthase with FT-4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non-alcoholic fatty liver disease: Results from two early-phase randomized trials.
    Beysen C; Schroeder P; Wu E; Brevard J; Ribadeneira M; Lu W; Dole K; O'Reilly T; Morrow L; Hompesch M; Hellerstein MK; Li K; Johansson L; Kelly PF
    Diabetes Obes Metab; 2021 Mar; 23(3):700-710. PubMed ID: 33289350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease.
    Kawano Y; Cohen DE
    J Gastroenterol; 2013 Apr; 48(4):434-41. PubMed ID: 23397118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans.
    Charidemou E; Ashmore T; Li X; McNally BD; West JA; Liggi S; Harvey M; Orford E; Griffin JL
    JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31145699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS).
    Qureshi W; Santaren ID; Hanley AJ; Watkins SM; Lorenzo C; Wagenknecht LE
    BMJ Open Diabetes Res Care; 2019; 7(1):e000691. PubMed ID: 31543975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
    Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
    J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids.
    Smith U; Kahn BB
    J Intern Med; 2016 Nov; 280(5):465-475. PubMed ID: 27699898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Nicotinamide Phosphoribosyltransferase and de novo Lipogenesis in Nonalcoholic Fatty Liver Disease.
    Amirkalali B; Sohrabi MR; Esrafily A; Jalali M; Gholami A; Hosseinzadeh P; Keyvani H; Shidfar F; Zamani F
    Med Princ Pract; 2017; 26(3):251-257. PubMed ID: 28092906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.
    Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption.
    Sanders FWB; Acharjee A; Walker C; Marney L; Roberts LD; Imamura F; Jenkins B; Case J; Ray S; Virtue S; Vidal-Puig A; Kuh D; Hardy R; Allison M; Forouhi N; Murray AJ; Wareham N; Vacca M; Koulman A; Griffin JL
    Genome Biol; 2018 Jun; 19(1):79. PubMed ID: 29925420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.